Wattanapat Hospital Trang PCL (BKK:WPH) Research & Development: ฿0 Mil (TTM As of Mar. 2026)


BKK:WPH Wattanapat Hospital Trang PCL Ltd BKK:WPH
81 GF Score
Price ฿5.80
GF Value ฿9.74
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Wattanapat Hospital Trang PCL Research & Development?

Wattanapat Hospital Trang PCL BKK:WPH -0.85% 81 Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:WPH with a GF Score™ of 81/100 and a GF Value™ of ฿9.74 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Wattanapat Hospital Trang PCL's Research & Development for the three months ended in Mar. 2026 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0 Mil.

Wattanapat Hospital Trang PCL  (BKK:WPH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Wattanapat Hospital Trang PCL Research & Development Related Terms

Wattanapat Hospital Trang PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Wattanapat Hospital Trang PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wattanapat Hospital Trang PCL Research & Development Chart

Wattanapat Hospital Trang PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wattanapat Hospital Trang PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:WPH
81GF Score
Wattanapat Hospital Trang PCL Ltd BKK:WPH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wattanapat Hospital Trang PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
Wattanapat Hospital Trang PCL (BKK:WPH) has a Research & Development of ฿0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Wattanapat Hospital Trang PCL and its competitors.
Is Wattanapat Hospital Trang PCL's Research & Development too high?
Wattanapat Hospital Trang PCL's current Research & Development is ฿0 Mil. Overall, Wattanapat Hospital Trang PCL has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wattanapat Hospital Trang PCL's Research & Development compare to HCA and THC?
Wattanapat Hospital Trang PCL's Research & Development of ฿0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Wattanapat Hospital Trang PCL and its competitors. Wattanapat Hospital Trang PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattanapat Hospital Trang PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL (BKK:WPH) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿9.74, compared to a current price of ฿5.80 — trading 40.5% below its estimated fair value. The current Research & Development is ฿0 Mil. Wattanapat Hospital Trang PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Wattanapat Hospital Trang PCL (BKK:WPH), the current Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wattanapat Hospital Trang PCL (BKK:WPH) Overvalued in 2026?

Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL stock appears to be undervalued. The current stock price of ฿5.80 is trading 40.5% below its estimated GF Value™ of ฿9.74. GuruFocus considers Wattanapat Hospital Trang PCL to be Significantly Undervalued.

Key valuation signals for BKK:WPH:

  • Research & Development: ฿0 Mil
  • GF Value™: ฿9.74 vs. price of ฿5.80 (40.5% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the BKK:WPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wattanapat Hospital Trang PCL Business Description

Address 247/2 Phatalung Road, Tambon Thap Thiang, Amphur Muang, Trang, THA, 92000
Wattanapat Hospital Trang PCL Ltd is engaged in medical services. Its operations are carried on only in Thailand. The company offers a range of services including Orthopedic Clinic, Neurosurgery Clinic, Neurology and Brain Clinic, Surgical Clinic, Heart Clinic, Internal Medicine Clinic, Obstetrics and Gynecology Clinic, Gastrointestinal and Liver Clinic, Children's Clinic, Eye Clinic, ENT Clinic, Dental Clinic, Dermatology and Beauty Clinic, Health Promotion Center, Other Centers and Clinics.
81GF Score

Get the complete analysis for BKK:WPH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.80
Price
฿9.74
GF Value